Inflammatory Breast Cancer International Consortium | IBC-IC HomepageInflammatory Breast Cancer International Consortium | IBC-IC

Bora Lim, MD

Clinician + Researcher

Title(s)

  • Associate Professor, Breast Oncology, Baylor College of Medicine. Dan L. Duncan Comprehensive Cancer Center
  • Associate Director for Clinical Science, Lester and Sue Smith Breast Center
  • Director of Translational Research, Breast Cancer Research Program

Location(s)

  • Dan L. Duncan Comprehensive Cancer Center
  • 7200 Cambridge St.
  • 7th Floor
  • Houston, TX, 77030
  • United States of America
  • Phone: 713.798.1999

Research and Clinical Interests

IBC-Focused Research

Despite rapidly evolving therapeutic advancement in modern oncology, still more than 40,000 women and men succumb to metastatic breast cancers (mBC) caused deaths each year. To relieve the suffering of patients, I have focused on achieving the following goals over the last 10 years as a translational researcher.

1. Formulate novel therapeutic strategies to induce effective eradication of aggressive breast cancers—such as triple negative breast cancers, inflammatory breast cancers, and a subset of endocrine therapy-resistant luminal breast cancers.

2. Develop accompanying, robust selective biomarkers that will enrich the patient who will benefit from this innovative biomarker-driven clinical trials, integrating novel assays such as liquid biopsy, and multiomic analysis.

3. Create the biological map of breast cancer evolution through large collaborative efforts with leading edge labs that develop novel assays such as single cell genomics, spatial genomics, and proteogenomics.

As the Director of Translational Research of Breast Cancer Program and the Associate Director of Clinical Science of Lester and Sue Smith Breast Center, I plan to expand these goals by engaging the rich, basic-translational research environment at Baylor Community, to develop an innovative, early-phase therapeutics program.

Education and Board Certifications

MD

Ewha Womans University, School of Medicine, Seoul, Republic of Korea (1998-2004)

Clinical Internship

Surgery, Catholic Medical Center, Seoul, Republic of Korea (2004-2005)

Clinical Residency

Pennsylvania Hospital, University of Pennsylvania Health System, Philadelphia, PA (2007-2010)

Chief Medical Residency

Internal Medicine, Pennsylvania Hospital, University of Pennsylvania Health System, Philadelphia, PA (2010-2011)

Clinical Fellowship

Hematology-Oncology, Penn State Hershey Medical Center, Penn State College of Medicine, Hershey, PA (2011-2014)

Research Fellowship

Experimental therapeutics, Penn State Hershey Cancer Institute, El-Deiry Laboratory of Experimental Therapeutics, Hershey, PA (2012-2014)

Board Certification

Korean Medical/Surgical Board, 2004

Board Certification

Educational Commission for Foreign Medical Graduates, 2006

Board Certification

American Board of Internal Medicine, Specialty in Internal Medicine, 2010

Board Certification

American Board of Internal Medicine, Specialty in Hematology, 2014

Board Certification

American Board of Internal Medicine, Specialty in Oncology, 2014

Affiliations and Memberships

ASCO University Educational Review/Question Generation Committee Member, American Society of Clinical Oncology, Alexandria, VA

CME Committee Member, American Association for Cancer Research, Philadelphia, PA

Medical Advisory Council Member, Susan G. Komen Houston, Houston, TX

Breast Cancer Working Group Committee, Translational Working Group Committee, South Western Oncology Group, San Francisco, CA

Chief Family Physician, Jeju-Jaeil Family Clinic, Jeju, South Korea

Nocturnal Chief Physician, Bucheon Burn/Emergency Center, Bucheon, South Korea

General Volunteer Practitioner, Yong-san121st General Hospital, Seoul, South Korea

Supervised Physician, JM Dermatology Clinic, Seoul, South Korea

General Practitioner, Yeonsoo Central Hospital, Incheon, South Korea

Counseling Managing Physician, Korea Health Promotion Association, Incheon, South Korea

President of Student Body, Ewha Womans University School of Medicine Student Body, Seoul, South Korea

American College of Physicians, Member, 2011-2040

American Society of Clinical Oncology, Member, 2011-2040

American Society of Hematology, Member, 2011-2040

American Association for Cancer Research, Member, 2012-2040

Korean Society of Medical Oncology, Republic of Korea, Scientific Member, 2014-2040

South Western Oncology Group, Member, Translational research committee & Breast Working Group, 2015-2040

Metastasis Research Society, Member, 2017

Aspen Cancer Conference, CO, Member, 2017

TBCRC, Member, TNBC Working Group, 2021-present

Pennsylvania Society of Oncology and Hematology, PA, Member, 2012-2014

Harris County Medical Society, Houston, TX, Member, 2014-2040

Texas Medical Association, TX, Member, 2014-2040

Affiliated IBC-IC Center(s)

  • Dan L Duncan Comprehensive Cancer Center
  • Houston, Texas, 77030
  • Research + Treatment Center

Join IBC-IC

Become part of our international consortium of researchers, clinicians, advocates and centers worldwide dedicated to ending IBC.

IBCIC.org makes every effort to keep researcher information as up-to-date as possible.
Contact this researcher to confirm any information regarding his or her profile.